HomeELVN • NASDAQ
add
Enliven Therapeutics Inc
Previous close
$20.55
Day range
$20.32 - $20.82
Year range
$13.30 - $29.79
Market cap
1.22B USD
Avg Volume
540.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 28.58M | 16.18% |
Net income | -25.34M | -26.99% |
Net profit margin | — | — |
Earnings per share | -0.49 | — |
EBITDA | -28.50M | -16.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 490.50M | 57.02% |
Total assets | 503.89M | 54.07% |
Total liabilities | 15.42M | -30.28% |
Total equity | 488.47M | — |
Shares outstanding | 59.24M | — |
Price to book | 2.49 | — |
Return on assets | -17.72% | — |
Return on capital | -18.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.34M | -26.99% |
Cash from operations | -17.06M | 16.53% |
Cash from investing | -183.59M | -445.34% |
Cash from financing | 218.38M | 11,991.81% |
Net change in cash | 17.73M | 133.91% |
Free cash flow | -9.33M | -356.79% |
About
Founded
2016
Headquarters
Website
Employees
63
